Regulations require that clinical trials be adequately monitored for GCP compliance by a suitably trained/qualified monitor. However, monitoring of non-commercial trials does not always need the intensity traditionally employed by the pharmaceutical industry.
The R&D team can provide monitoring, or help you find an appropriate monitor. It is essential that monitoring costs are included in funding applications.
